KROS - Keros Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KROS is currently covered by 9 analysts with an average price target of $31.61. This is a potential upside of $16.44 (108.37%) from yesterday's end of day stock price of $15.17.

Keros Therapeutics 's activity chart (see below) currently has 32 price targets and 57 ratings on display. The stock rating distribution of KROS is 87.88% BUY and 12.12% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 30.71% with an average time for these price targets to be met of 47.9 days.

Highest price target for KROS is $26, Lowest price target is $15, average price target is $23.33.

Most recent stock forecast was given by GREG HARRISON from SCOTIABANK on 12-May-2025. First documented stock forecast 04-May-2020.

Currently out of the existing stock ratings of KROS, 29 are a BUY (87.88%), 4 are a HOLD (12.12%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$26

$11.52 (79.56%)

$41

3 months 9 days ago
(12-May-2025)

1/6 (16.67%)

$12.26 (89.23%)

215

Buy

$25

$10.52 (72.65%)

$40

3 months 13 days ago
(08-May-2025)

1/14 (7.14%)

$10.98 (78.32%)

113

Buy

$25

$10.52 (72.65%)

$43

4 months 12 days ago
(09-Apr-2025)

0/6 (0%)

$14.67 (142.01%)

Buy

$26

$11.52 (79.56%)

$111

5 months 25 days ago
(27-Feb-2025)

1/3 (33.33%)

$15.06 (137.66%)

74

Buy

$15

$0.52 (3.59%)

$105

7 months 4 days ago
(17-Jan-2025)

6/12 (50%)

$4.14 (38.12%)

59

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KROS (Keros Therapeutics ) average time for price targets to be met?

On average it took 47.9 days on average for the stock forecasts to be realized with a an average price target met ratio 30.71

Which analyst has the current highest performing score on KROS (Keros Therapeutics ) with a proven track record?

JOSEPH CATANZARO

Which analyst has the most public recommendations on KROS (Keros Therapeutics )?

Joseph Catanzaro works at PIPER SANDLER and has 9 price targets and 9 ratings on KROS

Which analyst is the currently most bullish on KROS (Keros Therapeutics )?

Thomas Smith with highest potential upside - $31.36

Which analyst is the currently most reserved on KROS (Keros Therapeutics )?

Julian Harrison with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?